Head-to-head · Cost-Efficiency Index
Citizen Meds vs Nouri
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Citizen Meds
Shoppers who want to buy a low-dose starting month without any subscription commitment.
Visit Citizen MedsNouri
Shoppers who want a flat any-dose price and are willing to prepay 6 months to get the lowest rate.
Visit NouriThe verdict
Citizen Meds and Nouri tie on the Cost-Efficiency Index at 64/100, so neither wins outright on the numbers. For most shoppers we'd start with Citizen Meds (ranked #176, a hair above #183) — Shoppers who want to buy a low-dose starting month without any subscription commitment. But Nouri is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Citizen Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Citizen Meds | Nouri |
|---|---|---|
| Cost-Efficiency Index | 64/100 | 64/100 |
| Semaglutide / mo | $125/mo (0.25 mg dose, compounded) | $175/mo (all doses, prepay plan, compounded) |
| Tirzepatide / mo | $145/mo (2.5 mg dose, compounded) | $225/mo (all doses, prepay plan, compounded) |
| Semaglutide / yr (modeled) | $1,500 | $2,100 |
| Tirzepatide / yr (modeled) | $1,740 | $2,700 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #176 | #183 |
Citizen Meds
64/100Where the value is
- No subscription — every month is a separate one-time purchase, so there's no auto-renewing commitment to cancel
- LegitScript badge genuinely renders on the live homepage (seal 11945825), correcting the prior claim of no certification
- PCCA compounding-pharmacy trade-association badge and PCAB-labeled imagery displayed
The tradeoffs
- The headline '$125'/'$145' price is Month-1-only at the lowest dose; the mandatory titration schedule pushes maintenance-dose months to $395-$545, roughly 3-4x the advertised figure
- No compounding pharmacy is named anywhere on the site
Nouri
64/100Where the value is
- 'Any dose, same price' means no dose-escalation surcharge — unlike most compounded-GLP-1 competitors
- Names a real, licensed 503A compounding pharmacy (F&F Pharmacies dba Jungle Jim's Pharmacy, Fairfield, OH) and a named prescribing physician (Dr. Michael Wasef, MD)
- Bundles nutrition planning, movement planning, and concierge care into every tier at no extra charge, per the site's own claim
The tradeoffs
- The advertised 'starting at' headline price ($120 semaglutide / $175 tirzepatide) is the 6-month PREPAY rate only — the true month-to-month price is 46% and 29% higher respectively ($175 / $225)
- The 30-day money-back guarantee explicitly excludes the monthly (no-prepay) plan
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.